InsiderClue
Insiders · Profile

Pons Jaume

PRESIDENT & CSO at ALX ONCOLOGY. Filing since 22 Mar 2021. CIK 0001816977

Company
Date
Role
Action
Shares
Amount
Of holding
ALXO ALX ONCOLOGY HOLDINGS INC
19 Feb 2025
PRESIDENT & CSO
Sold at will
1,326
$1.53K
0.2%
ALXO ALX ONCOLOGY HOLDINGS INC
30 Dec 2024
PRESIDENT & CSO
Sold at will
10,796
$17.06K
1.8%
ALXO ALX ONCOLOGY HOLDINGS INC
14 Aug 2024
PRESIDENT & CSO
Sold at will
1,937
$5.00K
0.3%
ALXO ALX ONCOLOGY HOLDINGS INC
11 Jul 2024
PRESIDENT & CSO
Sold on a plan
20,000
$158.08K
3.3%
ALXO ALX ONCOLOGY HOLDINGS INC
1 Jul 2024
PRESIDENT & CSO
Sold at will
10,758
$62.60K
1.8%
ALXO ALX ONCOLOGY HOLDINGS INC
4 Jun 2024
PRESIDENT & CSO
Sold on a plan
20,000
$168.65K
3.2%
ALXO ALX ONCOLOGY HOLDINGS INC
6 May 2024
PRESIDENT & CSO
Sold on a plan
20,000
$318.33K
3.2%
ALXO ALX ONCOLOGY HOLDINGS INC
16 Apr 2024
PRESIDENT & CSO
Sold on a plan
50,000
$710.20K
7.6%
ALXO ALX ONCOLOGY HOLDINGS INC
4 Apr 2024
PRESIDENT & CSO
Sold on a plan
20,000
$223.04K
3.1%
ALXO ALX ONCOLOGY HOLDINGS INC
29 Dec 2023
President & CSO
Sold at will
7,179
$107.97K
1.1%
ALXO ALX ONCOLOGY HOLDINGS INC
30 Jun 2023
President & CEO
Sold at will
3,208
$23.55K
0.6%
ALXO ALX ONCOLOGY HOLDINGS INC
29 Dec 2022
President & CEO
Sold, plan not stated
3,232
$35.78K
0.6%
ALXO ALX ONCOLOGY HOLDINGS INC
19 Oct 2021
President & CEO
Sold, plan not stated
33,400
$1.81M
7.0%
ALXO ALX ONCOLOGY HOLDINGS INC
20 Sep 2021
President & CEO
Sold, plan not stated
16,700
$1.24M
3.5%
ALXO ALX ONCOLOGY HOLDINGS INC
19 Aug 2021
President & CEO
Sold, plan not stated
16,700
$1.02M
3.4%
ALXO ALX ONCOLOGY HOLDINGS INC
19 Jul 2021
President & CEO
Sold, plan not stated
16,700
$911.25K
3.3%
ALXO ALX ONCOLOGY HOLDINGS INC
21 Jun 2021
President & CEO
Sold, plan not stated
16,700
$978.48K
3.2%
ALXO ALX ONCOLOGY HOLDINGS INC
19 May 2021
President & CEO
Sold, plan not stated
16,700
$930.28K
3.1%
ALXO ALX ONCOLOGY HOLDINGS INC
19 Apr 2021
President & CEO
Sold, plan not stated
16,700
$962.43K
3.0%
ALXO ALX ONCOLOGY HOLDINGS INC
22 Mar 2021
President and CEO
Sold, plan not stated
16,700
$1.14M
2.9%
20 decisions on file.